| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.0007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |